Table 3: Associations between prenatal lead exposures and preadolescent eGFRCysC2012, stratified according to BMI status.
Normal weight | Overweight | Obese | |||||||
---|---|---|---|---|---|---|---|---|---|
Estimate (95% CI) | P-value | n | Estimate (95% CI) | P-value | n | Estimate (95% CI) | P-value | n | |
2T BLL | 1.76 (−2.4, 6.0) | 0.42 | 239 | −10.49 (−18.1, −2.8) | 0.008 | 108 | 1.66 (−5.9, 9.2) | 0.67 | 104 |
3T BLL | 2.94 (−1.5, 7.4) | 0.20 | 196 | −9.97 (−17.6, −2.4) | 0.01 | 95 | 4.29 (−4.7, 13.2) | 0.34 | 82 |
Cord BLL | 1.94 (−2.9, 6.8) | 0.43 | 195 | −8.87 (−16.8, −0.9) | 0.03 | 82 | −6.96 (−15.9, 2.0) | 0.13 | 84 |
Tibia Pb | 0.19 (−0.2, 0.6) | 0.29 | 195 | −0.13 (−0.8, 0.5) | 0.69 | 84 | −0.06 (−0.7, 0.6) | 0.84 | 75 |
Patella Pb | −0.12 (−0.4, 0.2) | 0.47 | 194 | −0.52 (−1.3, 0.3) | 0.22 | 81 | −0.16 (−0.8, 0.5) | 0.60 | 76 |
2T, second trimester; 3T, third trimester; BLL, blood lead level after ln-transformation.